Nasotracheal intubation over a bougie vs. non-bougie intubation: a prospective randomised, controlled trial in older children and adults using videolaryngoscopy.
R O Abrons, M B Zimmerman, Y M S El-Hattab
https://pubmed.ncbi.nlm.nih.gov/28921537/Actively Recruiting
Led by University Hospitals Coventry and Warwickshire NHS Trust · Updated on 2026-06-15
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are comparing two methods of inserting a breathing tube through the nose into the windpipe nasotracheal intubation used during surgeries inside the mouth or jaw. The study aims to see if using a flexible fibrescope reduces nasal trauma and nosebleed compared to the common method using a video laryngoscope. Both devices are currently used in practice, but it is unclear which causes less nasal injury. Patients will be randomly assigned to receive nasotracheal intubation with either a flexible fibrescope or a video laryngoscope. Before intubation, all patients will receive a nasal decongestant spray. In the fibrescope group, the device is inserted first to visually guide the breathing tube through the most open nostril into the trachea. In the video laryngoscope group, the tube is inserted blindly through the nose and then guided into the trachea using the laryngoscopes camera. Participants will be monitored closely during intubation, with measurements including nasal trauma severity, smoothness of tube insertion, intubation time, and success rate at first attempt. After surgery, patients will be assessed within 3 to 24 hours for nasal bleeding, discomfort, and sore throat. If bleeding continues, a specialist will review the patient up to 72 hours. The study plans to enroll 200 patients and will be completed by January 2027.
CONDITIONS
Fibrescope vs Videolaryngoscope for Nasotracheal Intubation
C
Charles Pairaudeau, FRCA
M
Maria Turslove
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospitals Coventry and Warwickshire NHS Trust
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo nasotracheal intubation using either a flexible fibrescope or a video laryngoscope as assigned. Nasal decongestant spray is applied before intubation.
1 visit (during surgery)
Duration - Up to 3 days
Participants are assessed within 3 to 24 hours after intubation for nasal bleeding, discomfort, and sore throat. Additional review may occur up to 72 hours if bleeding continues.
1 to 2 visits (postoperative)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
R O Abrons, M B Zimmerman, Y M S El-Hattab
https://pubmed.ncbi.nlm.nih.gov/28921537/Yoshinari Morimoto, Mitsutaka Sugimura, Yohsuke Hirose...
https://pubmed.ncbi.nlm.nih.gov/16527796/Teena Bansal, Suresh Singhal, Komal Dhingra
https://pubmed.ncbi.nlm.nih.gov/36590192/Z A El-Seify, A M Khattab, A A Shaaban...
https://pubmed.ncbi.nlm.nih.gov/20682569/Stephen R Collins, Randal S Blank
https://pubmed.ncbi.nlm.nih.gov/24891196/Y C Kim, S H Lee, G J Noh...
https://pubmed.ncbi.nlm.nih.gov/10960403/University Hospitals Coventry and Warwickshire NHS Trust
Lead Sponsor